Intracerebral administration of interleukin-12 (IL-12) and IL-18 modifies the course of mouse scrapie

BMC Veterinary Research

Volumn 2, Issue , 2006, Pages

  Pasquali, Paolo ^a   Nonno, Romolo ^a   Mandara, Maria Teresa ^b   Di Bari, Michele Angelo ^a   Ricci, Giovanni ^b   Petrucci, Paola ^a   Capuccini, Silvia ^b   Cartoni, Claudia ^a   Macrì, Agostino ^a   Agrimi, Umberto ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MUS;

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; C57BL MOUSE; DRUG COMBINATION; FEMALE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM; MOUSE; SCRAPIE; TIME;

ANIMALS; DRUG THERAPY, COMBINATION; FEMALE; INJECTIONS, INTRAVENTRICULAR; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-18; MICE; MICE, INBRED C57BL; SCRAPIE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33846616864     PISSN: None     EISSN: 17466148     Source Type: Journal    
DOI: 10.1186/1746-6148-2-37     Document Type: Article

References (52)

1. Prusiner SB, DeArmond SJ: Prion diseases and neurodegeneration. Annu Rev Neurosci 1994, 17:311-39.
2. Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, Hayes SF, Caughey B: The most infectious prion protein particles. Nature 2005, 437:257-261.
3. Cunningham C, Wilcockson DC, Boche D, Perry VH: Comparison of inflammatory and acute-phase responses in the brain and peripheral organs of the ME7 model of prion disease. J Virol 2005, 79:5174-84.
4. Porter DD, Porter HG, Cox NA: Failure to demonstrate a humoral immune response to scrapie infection in mice. J Immunol 1973, 111:1407-10.
5. Williams AE, Lawson LJ, Perry VH, Fraser H: Characterisation of the microglial response in murine scrapie. Neuropathol Appl Neurobiol 1994, 20:47-55.
6. Mabbott NA, Bruce ME: The immunobiology of TSE diseases. J Gen Virol 2001, 82:2307-18.
7. Mabbott NA, Mackay F, Minns F, Bruce ME: Temporary inactivation of follicular dendritic cells delays neuroinvasion of scrapie. Nat Med 2000, 6:719-20.
8. Riemer C, Queck I, Simon D, Kurth R, Baier M: Identification of Upregulated Genes in Scrapie-Infected Brain Tissue. J Virol 2000, 74:10245-1024.
9. Xiang W, Windl O, Wunsch G, Dugas M, Kohlmann A, Dierkes N, Westner IM, Kretzschmar HA: Identification of differentially expressed genes in scrapie-infected mouse brains by using global gene expression technology. J Virol 2004, 78:11051-11060.
10. Outram GW, Dickinson AG, Fraser H: Reduced susceptibility to scrapie in mice after steroid administration. Nature 1974, 249:855-6.
11. Fraser H, Dickinson AG: Studies of the lymphoreticular system in the pathogenesis of scrapie: the role of spleen and thymus. J Comp Path 1978, 88:563-73.
12. Dickinson A, Fraser H, McConnell I, Outram GW: Mitogenic stimulation of the host enhances susceptibility to scrapie. Nature 1978, 272:54-5.
13. Brown KL, Stewart K, Ritchie D, Mabbott NA, Williams A, Fraser H, Morrison WI, Bruce ME: Scrapie replication in lymphoid tissue depends on PrP-expressing follicular dendritic cells. Nat Med 1999, 5:1308-13.
14. Mabbott NA, Farquhar CF, Brown KL, Bruce ME: Involvement of the immune system in TSE pathogenesis. Immunol Today 1998, 19:201-3.
15. Montrasio F, Frigg R, Glatzel M, Klein MA, Mackay F, Aguzzi A, Weissmann C: Impaired prion replication in spleens of mice lacking functional follicular dendritic cells. Science 2000, 288:1257-9.
16. Sc from the gut. J Gen Virol 2002, 83:267-71.
17. Aguzzi A, Heppner FL, Heikenwalder M, Prinz M, Mertz K, Seeger H, Glatzel M: Immune system and peripheral nerves in propagation of prions to CNS. British Medical Bulletin 2003, 66:141-59.
18. Mohan J, Bruce ME, Mabbott NA: Neuroinvasion by scrapie following inoculation via the skin is independent of migratory Langerhans cells. J Virol 2005, 79:1888-1897.
19. Santambrogio L, Belyanskaya SL, Fischer FR, Cipriani B, Brosnan CF, Ricciardi-Castagnoli P, Stern LJ, Strominger JL, Riese R: Developmental plasticity of CNS microglia. Proc Natl Acad Sci USA 2001, 98:6295-300.
20. Rezaie P, Lantos PL: Microglia and the pathogenesis of spongiform encephalopathies. Brain Res Rev 2001, 35:55-72.
21. Betmouni S, Perry V: The acute inflammatory response in CNS following injection of prion brain homogenate or normal brain homogenate. Neuropathol Appl Neurobiol 1999, 25:20-8.
22. Brown AR, Webb J, Rebus S, Walker R, Williams A, Fazakerley JK: Inducible cytokine gene expression in the brain in the ME7/CV mouse model of scrapie is highly restricted, is at a strikingly low level relative to the degree of gliosis and occurs only late in disease. J Gen Virol 2003, 84:2605-11.
23. Campbell IL, Eddleston M, Kemper P, Oldstone MB, Hobbs MV: Activation of cerebral cytokine gene expression and its correlation with onset of reactive astrocyte and acute-phase response gene expression in scrapie. J Virol 1994, 68:2383-7.
24. Kim JI, Ju WK, Choi JH, Choi E, Carp RI, Wisniewski HM, Ki YS: Expression of cytokine genes and increased nuclear factor-kappa B activity in the brains of scrapie-infected mice. Brain Res Mol Brain Res 1999, 73:17-27.
25. Peyrin JM, Lasmezas CI, Haik S, Tagliavini F, Salmona M, Williams A, Richie D, Deslys JP, Dormont D: Microglial cells respond to amyloidogenic PrP peptide by the production of inflammatory cytokines. Neuroreport 1999, 10:723-9.
26. Schultz J, Schwarz A, Neidhold S, Burwinkel M, Riemer C, Simon D, Kopf M, Otto M, Baier M: Role of interleukin-1 in prion disease-associated astrocyte activation. Am J Pathol 2004, 165:671-8.
27. Williams AE, van Dam AM, Ritchie D, Eikelenboom P, Fraser H: Immunocytochemical appearance of cytokines, prostaglandin E-2 and lipocortin-1 in the CNS during the incubation period of murine scrapie correlates with progressive PrP accumulations. Brain Res 1997, 754:171-80.
28. Riemer C, Neidhold S, Burwinkel M, Schwarz A, Schultz J, Kratzschmar J, Monning U, Baier M: Gene expression profiling of scrapie-infected brain tissue. Biochem Biophys Res Commun 2004, 323:556-64.
29. Okamura H, Kashiwamura S, Tsutsui H, Yoshimoto T, Nakanishi K: Regulation of interferon-γ production by IL-12 and IL-18. Curr Opin Immunol 1998, 10:259-64.
30. Trembleau S, Germann T, Gately MK, Adorini A: The role of IL-12 in the induction of organ-specific autoimmune diseases. Immunol Today 1995, 16:383-6.
31. Bi Z, Quandt P, Komatsu T, Barna M, Reiss CS: IL-12 promotes enhanced recovery from vescicular stomatitis virus infection of the central nervous system. J Immunol 1995, 155:5684-9.
32. Athie-Morales V, Smits HH, Cantrell DA, Hilkens CMU: Sustained IL-12 Signaling Is Required for Th1 Development. J Immunol 2004, 172:61-69.
33. Komatsu T, Reiss CS: IFN-γ is not required in the IL-12 response to vescicular stomatitis virus infection on the olfactory bulb. J Immunol 1997, 159:3444-52.
34. Kohno K, Kataoka J, Ohtsuki T, Suemoto Y, Okamoto I, Usui M, Ikeda M, Kurimoto M: Interferon-γ inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effects independently of IL-12. J Immunol 1997, 158:1541-50.
35. Netea M, Kullberg BJ, Verschueren I, Van der Meer JWM: Interleukin-18 induces production of proinflammatory cytokines in mice: no intermediate role for the cytokines of the tumor necrosis factor family and interlaukin- Iβ. Eur J Immunol 2000, 30:3057-60.
36. Mori I, Hossain MJ, Takeda K, Okamura H, Imai Y, Kohsaka S, Kimura Y: Impaired microglial activation in the brain of IL-18-gene-disrupted mice after neurovirulent influenza A virus infection. Virology 2001, 287:163-70.
37. Thackray AM, McKenzie AN, Klein MA, Lauder A, Bujdoso R: Accelerated prion disease in the absence of interleukin-10. J Virol 2004, 78:13697-13707.
38. Westaway D, Mirenda CA, Foster D, Zebarjadian Y, Scott M, Torchia M, Yang SL, Serban H, DeArmond SJ, Ebeling C, Prusiner SB, Carlson GA: Paradoxical shortening of scrapie incubation times by expression of prion protein transgenes derived from long incubation period mice. Neuron 1991, 7:59-68.
39. Satoh J, Kurohara K, Yukitake M, Kuroda Y: Constitutive and cytokine-inducible expression of prion protein gene in human neural cell lines. J Neuropathol Exp Neurol 1998, 57:131-9.
40. Kretzschmar HA, Prusiner SB, Stowring LE, DeArmond SJ: Scrapie prion proteins are synthesized in neurons. Am J Pathol 1986, 122:1-5.
41. Brown DR, Besinger A, Herms JW, Kretzschmar HA: Microglial expression of the prion protein. Neuroreport 1998, 9:1425-29.
42. Lainé J, Marc ME, Sy MS, Axelrad H: Cellular and subcellular morphological localization of the normal prion protein in the rodent cerebellum. Eur J Neurosci 2001, 14:47-56.
43. Durig J, Giese A, Schulz-Schaeffer W, Rosenthal C, Schmucker U, Bieschke J, Duhrsen U, HA Kretzschmar: Differential constitutive and activation-dependent expression of prion protein in human peripheral blood leucocytes. Br J Haematol 2000, 108:488-95.
44. Klein MA, Frigg R, Flechsig E, Raeber AJ, Kalinke U, Bluethmann H, Bootz F, Suter M, Zinkernagel RM, Aguzzi A: A crucial role for B cells in neuroinvasive scrapie. Nature 1997, 390:687-90.
45. Mabbott NA, Brown KL, Manson J, Bruce ME: T-lymphocyte activation and the cellular form of the prion protein. Immunology 1997, 92:161-5.
46. Muramoto T, Kitamoto T, Tateishi J, Goto I: Accumulation of abnormal prion protein in mice infected with Creutzfeldt-Jacob disease via intra-peritoneal route: a sequential study. Am J Pathol 1993, 143:1470-9.
47. Muramoto T, Kitamoto T, Tateishi J, Goto I: The sequential development of abnormal protein accumulation in mice with Creutzfeldt-Jacob disease. Am J Pathol 1992, 140:1411-20.
48. Betmouni S, Perry VH, Gordon S: Evidence for an early inflammatory response in the central nervous system of mice with scrapie. Neuroscience 1996, 74:1-5.
49. Baker CA, Martin D, Manuelidis L: Microglia from Creutzfeldt-Jakob Disease-Infected brains are infectious and show specific mRNA activation profiles. J Virol 2002, 76:10905-13.
50. Muhleisen H, Gehrmann J, Meyermann R: Reactive microglia in Creutzfeldt-Jakob disease. Neuropathol Appl Neurobiol 1995, 21:505-17.
51. McLean AR, Bostock CJ: Scrapie infections initiated at varying doses: an analysis of 117 titration experiments. Phil Trans R Soc Lond B 2000, 355:1043-50.
52. Prusiner SB, Cochran SP, Groth DF, Downey DE, Bowman KA, Martinez HM: Measurement of the scrapie agent using an incubation time interval assay. Ann Neurol 1982, 11:353-8.